CGRP in migraine: current therapeutics, future implications and potential off-target effects - a podcast by BMJ Group

In this podcast, JNNP's Podcast Editor, Colin Mahoney, interviews Dr Jason Ray (Neurology, Alfred Health, and Department of Neuroscience, Monash University, Melbourne). Dr Ray discusses the role of calcitonin gene related peptide in migraine and the growing body of evidence for the role of therapies directed against this protein in migraine and beyond. He also highlights emerging off-target side effects to monitor for.

Related article: https://jnnp.bmj.com/content/92/12/1325

Further episodes of JNNP podcast

Further podcasts by BMJ Group

Website of BMJ Group